Active Biotechnology Stocks (BNVI, GENZ, CELG, CTIC)

Bionovo Inc. (NASDAQ:BNVI) is up 19.41% to $0.525 on 7.35 million shares. Yesterday, the company announced that Patent and Trademark Office (USPTO) has issued a patent covering a method of using the Company's drug candidate Bezielle (BZL101) for the treatment of metastatic breast cancer. Subscribe to daily free stock newsletter by visiting:  http://www.PennyStockPickReport.com

Genzyme Corporation (NASDAQ:GENZ) advances 1.75% to $54.52 on 2.55 million shares. The company reported first quarter net income of $0.37 per share Wednesday morning, which declined from $0.82 per share last year. The consensus estimate was for EPS of $0.33. Revenues fell to $1.07 billion from $1.15 billion last year.

Celgene Corporation (NASDAQ:CELG) drops 3.32% to $59.08 on 1.99 million shares. Cell Therapeutics, Inc. (NASDAQ:CTIC) falls 1.20% to $0.642 on 1.04 million shares.

About http://www.PennyStockPickReport.com Penny Stock Pick Report offers stock newsletter on OTC, PINKSHEETS ,OTCBB, AMEX, NASDAQ and NYSE stock exchange. Our subscribers receive daily up to date stock information on hot stocks, most active movers, top gainers, penny stocks and much more. If you wish to feature your organization on our website then you can contact us at the email given below.